What is Cadrenal Therapeutics, Inc. Common Stock's Market Cap?

Cadrenal Therapeutics, Inc. Common Stock's Market Cap is $4.3M, based on as-reported figures from SEC (XBRL) filings.

What is Cadrenal Therapeutics, Inc. Common Stock's Net Income (TTM)?

Cadrenal Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.9M, based on as-reported figures from SEC (XBRL) filings.

What is Cadrenal Therapeutics, Inc. Common Stock's EBITDA?

Cadrenal Therapeutics, Inc. Common Stock's EBITDA is -$12.0M, based on as-reported figures from SEC (XBRL) filings.

What is Cadrenal Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Cadrenal Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.33, based on as-reported figures from SEC (XBRL) filings.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financial Statements

Cadrenal Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG019STRT39

XNAS · usd

1.20▼ 0.02 (-1.64%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.22

Day's Range1.16 – 1.26

52-Week Range1.16 – 14.64

Volume154.6K

Avg Volume786.2K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed2023-01-20

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cadrenal Therapeutics, Inc. Common Stock (CVKD)

What is Cadrenal Therapeutics, Inc. Common Stock's Market Cap?: Cadrenal Therapeutics, Inc. Common Stock's Market Cap is $4.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cadrenal Therapeutics, Inc. Common Stock's Net Income (TTM)?: Cadrenal Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cadrenal Therapeutics, Inc. Common Stock's EBITDA?: Cadrenal Therapeutics, Inc. Common Stock's EBITDA is -$12.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cadrenal Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Cadrenal Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.33, based on as-reported figures from SEC (XBRL) filings.